Cargando…

Gymnemasylvestre derived compounds inhibit GSH depletion and increase cGMP and nitric oxide to attenuate advanced glycation end products induced hypertrophic growth in renal tubular epithelial cells

The accumulation of advanced glycation end products (AGE) plays significant role in developing tubular hypertrophy during diabetic nephropathy (DN). Reactive oxygen species and nitric oxide (NO) are directly involved in the progression of DN. We have studied the effect of standardized Gymnemasylvest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vidyashankar, Satyakumar, Babu, Uddagiri Venkanna, Patki, Pralhad Sadashiv
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598397/ https://www.ncbi.nlm.nih.gov/pubmed/28962295 http://dx.doi.org/10.1016/j.toxrep.2014.08.015

Ejemplares similares

Ashwagandha (Withania somnifera) supercritical CO(2) extract derived withanolides mitigates Bisphenol A induced mitochondrial toxicity in HepG2 cells
por: Vidyashankar, Satyakumar, et al.
Publicado: (2014)

Water Soluble Components of ‘Osteocare’ Promote Cell Proliferation, Differentiation, and Matrix Mineralization in Human Osteoblast-Like SaOS-2 Cells
por: Varma, Sandeep R., et al.
Publicado: (2014)

Cystone – An ayurvedic polyherbal formulation inhibits adherence of uropathogenic E. coli and modulates H(2)O(2)-induced toxicity in NRK-52E cells
por: Vidyashankar, Satyakumar, et al.
Publicado: (2010)

Extract of a polyherbal formulation ameliorates experimental nonalcoholic steatohepatitis
por: Azeemuddin, Mohammed, et al.
Publicado: (2015)

HD-03/ES: A Herbal Medicine Inhibits Hepatitis B Surface Antigen Secretion in Transfected Human Hepatocarcinoma PLC/PRF/5 Cells
por: Varma, Sandeep R., et al.
Publicado: (2013)

Phosphodiesterase 9A Controls Nitric-oxide Independent cGMP and Hypertrophic Heart Disease
por: Lee, Dong I., et al.
Publicado: (2015)

Requirement for cGMP in Nerve Cell Death Caused by Glutathione Depletion
por: Li, Yonghong, et al.
Publicado: (1997)

NO/cGMP signalling in platelets
por: Schinner, Elisabeth, et al.
Publicado: (2009)

cGMP and cardiac hypertrophy
por: Perera, Ruwan K, et al.
Publicado: (2015)

Analysis of cGMP signalling with transgenic mice expressing FRET-based cGMP sensors
por: Wen, Lai, et al.
Publicado: (2013)

Transient kinetics of a cGMP-dependent cGMP-specific phosphodiesterase from Dictyostelium discoideum
Publicado: (1984)

Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling
por: Mullershausen, Florian, et al.
Publicado: (2003)

Extracellular cGMP Modulates Learning Biphasically by Modulating Glycine Receptors, CaMKII and Glutamate-Nitric Oxide-cGMP Pathway
por: Cabrera-Pastor, Andrea, et al.
Publicado: (2016)

PDE5 says NO to cGMP
por: LeBrasseur, Nicole
Publicado: (2003)

cGMP steers axons home
por: LeBrasseur, Nicole
Publicado: (2002)

A novel pathway of cGMP
por: Kuhn, Michaela, et al.
Publicado: (2011)

The role of cGMP and PKG in cardioprotection
por: Downey, James M, et al.
Publicado: (2009)

NO-cGMP signalling and cancer therapy
por: Bian, Ka, et al.
Publicado: (2013)

Role of cGMP in fat and metabolism
por: Pfeifer, Alexander, et al.
Publicado: (2013)

cGMP Signaling in Photoreceptor Degeneration
por: Li, Shujuan, et al.
Publicado: (2023)

Inhibition of the TGFβ signalling pathway by cGMP and cGMP‐dependent kinase I in renal fibrosis
por: Schinner, Elisabeth, et al.
Publicado: (2017)

cGMP: a unique 2nd messenger molecule – recent developments in cGMP research and development
por: Friebe, Andreas, et al.
Publicado: (2019)

Homogeneous single-label cGMP detection platform for the functional study of nitric oxide-sensitive (soluble) guanylyl cyclases and cGMP-specific phosphodiesterases
por: Kopra, Kari, et al.
Publicado: (2020)

Elevated retinal cGMP is not associated with elevated circulating cGMP levels in a canine model of retinitis pigmentosa
por: Occelli, Laurence M., et al.
Publicado: (2022)

The 10th International Conference on cGMP 2022: recent trends in cGMP research and development—meeting report
por: Friebe, Andreas, et al.
Publicado: (2023)

cGMP-independent nitric oxide signaling and regulation of the cell cycle
por: Cui, Xiaolin, et al.
Publicado: (2005)

Structural and mechanistic insights into cGMP signaling
por: Rauch, Annika, et al.
Publicado: (2009)

Vascular and renal function of cGMP signalling
por: Schlossmann, Jens, et al.
Publicado: (2011)

Role of cGMP/PKG in fat tissue
por: Pfeifer, Alexander
Publicado: (2011)

cGMP becomes a drug target
por: Schlossmann, Jens, et al.
Publicado: (2012)

NO-H(2)S interactions involve cGMP
por: Papapetropoulos, Andreas
Publicado: (2013)

cGMP kinase: past, presence and future
por: Hofmann, Franz, et al.
Publicado: (2013)

Natriuretic peptides and cGMP in metabolic disease
por: Collins, Sheila
Publicado: (2015)

NO-dependent cGMP signalling in neurons and astrocytes
por: Giesen, Jan, et al.
Publicado: (2015)

Modulating cGMP to Treat Lung Diseases
por: Ghofrani, Hossein-Ardeschir, et al.
Publicado: (2009)

Natriuretic Peptides/cGMP/cGMP-Dependent Protein Kinase Cascades Promote Muscle Mitochondrial Biogenesis and Prevent Obesity
por: Miyashita, Kazutoshi, et al.
Publicado: (2009)

Forty-five years of cGMP research in Dictyostelium: understanding the regulation and function of the cGMP pathway for cell movement and chemotaxis
por: van Haastert, Peter J. M., et al.
Publicado: (2021)

The ANP/cGMP/cGMP-dependent protein kinase pathway counteracts Angiotensin II-stimulated calcium mobilization in cardiac myocytes
por: Klaiber, Michael, et al.
Publicado: (2009)

The cGMP system in normal and degenerating mouse neuroretina: New proteins with cGMP interaction potential identified by a proteomics approach
por: Rasmussen, Michel, et al.
Publicado: (2020)

Mechanisms of Activity-dependent Plasticity in Cellular Nitric Oxide-cGMP Signaling
por: Halvey, Edward J., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_joinjm4g00rvkjik0tlrrvugk1